Trial analysis reveals almost all adults with hypertensive chronic kidney disease would benefit from intensive blood pressure lowering – FirstWord Pharma
Trial analysis reveals almost all adults with hypertensive chronic kidney disease would benefit from intensive blood pressure lowering FirstWord Pharma
Using estimated risks and preferences to justify intensive BP control in CKD patients